Tagged: targentas

Biotecher ImmunoLogik Syncs with aescuvest to Back Anti-HIV Drug, Nears Initial Funding Goal

The ImmunoLogik GmbH and the University of Erlangen-Nuremberg HIV research team have synced with aescuvest to raise funding for an innovative new drug. To date, the biotech company has raised more than €77,940, or more than 75% of its initial €100,000 goal. ImmunoLogik GmbH, a biotechnology company… Read More

Send this to a friend